​

Evoke Pharma (EVOK) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Evoke Pharma Revenue Highlights

Latest Revenue (Y)

$10.25T

Latest Revenue (Q)

$3.31M

Main Segment (Y)

Pharmaceutical Products

Evoke Pharma Revenue by Period

Evoke Pharma Revenue by Year

DateRevenueChange
2024-12-31$10.25T197840992.69%
2023-12-31$5.18M106.51%
2022-12-31$2.51M55.04%
2021-12-31$1.62M6929.00%
2020-12-31$23.02K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Evoke Pharma generated $10.25T in revenue during NA 2024, up 197840992.69% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Evoke Pharma Revenue by Quarter

DateRevenueChange
2024-12-31$3.31M24.65%
2024-09-30$2.65M4.03%
2024-06-30$2.55M47.01%
2024-03-31$1.74M3.55%
2023-12-31$1.68M7.24%
2023-09-30$1.56M38.14%
2023-06-30$1.13M39.60%
2023-03-31$810.41K1.76%
2022-12-31$796.37K-4.29%
2022-09-30$832.10K80.19%
2022-06-30$461.80K10.38%
2022-03-31$418.38K16.03%
2021-12-31$360.57K-61.25%
2021-09-30$930.45K293.20%
2021-06-30$236.63K161.70%
2021-03-31$90.42K292.79%
2020-12-31$23.02K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31--

Evoke Pharma generated $3.31M in revenue during Q4 2024, up 24.65% compared to the previous quarter, and up 211.69% compared to the same period a year ago.

Evoke Pharma Revenue Breakdown

Evoke Pharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Pharmaceutical Products$10.25M

Evoke Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 24: Pharmaceutical Products (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25
Pharmaceutical Products$3.75M$3.08M

Evoke Pharma's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Pharmaceutical Products (100.00%).

Evoke Pharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
EVOKEvoke Pharma$10.25T$3.31M
IMCCIM Cannabis$48.80M$12.06M
BFRIBiofrontera$37.30M$8.59M
SBFMSunshine Biopharma$34.87M$8.90M
SNOASonoma Pharmaceuticals$12.73M$3.75M
CYCNCyclerion Therapeutics$2.00M$81.00K
XTLBXTL Biopharmaceuticals--
PLRZPolyrizon--
NRSNNeuroSense Therapeutics--

EVOK Revenue FAQ

What is Evoke Pharma’s yearly revenue?

Evoke Pharma's yearly revenue for 2024 was $10.25T, representing an increase of 197840992.69% compared to 2023. The company's yearly revenue for 2023 was $5.18M, representing an increase of 106.51% compared to 2022. EVOK's yearly revenue for 2022 was $2.51M, representing an increase of 55.04% compared to 2021.

What is Evoke Pharma’s quarterly revenue?

Evoke Pharma's quarterly revenue for Q4 2024 was $3.31M, a 24.65% increase from the previous quarter (Q3 2024), and a 97.40% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $2.65M, a 4.03% increase from the previous quarter (Q2 2024), and a 69.83% increase year-over-year (Q3 2023). EVOK's quarterly revenue for Q2 2024 was $2.55M, a 47.01% increase from the previous quarter (Q1 2024), and a 125.51% increase year-over-year (Q2 2023).

What is Evoke Pharma’s revenue growth rate?

Evoke Pharma's revenue growth rate for the last 3 years (2022-2024) was 408563686.43%, and for the last 5 years (2020-2024) was 44523957328.32%.

What are Evoke Pharma’s revenue streams?

Evoke Pharma's revenue streams in c 24 are Pharmaceutical Products

What is Evoke Pharma’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Evoke Pharma was Pharmaceutical Products. This segment made a revenue of $10.25M, representing 100.00% of the company's total revenue.